Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Natural Protein Tinagl1 May Prevent Breast Cancer Cell Growth and Metastasis

Natural Protein Tinagl1 May Prevent Breast Cancer Cell Growth and Metastasis

On 3 January 2019, Cancer Cell published a study attracting strong interest among scientists and oncology professionals. It discovered that a drug derived from the natural protein Tinagl1 prevented triple-negative breast cancer growth and metastasis . The drug targets EGFR and integrin / FAK , two cellular pathways important in cancer development.

Triple-negative breast cancer has aggressive biology and accounts for % 13-17 of all breast cancers. Its recurrence rate is higher, and treatment options are more limited than for other breast cancers.

Note: The figure below shows breast cancer types.

breast cancer types luminal a b her2 positive triple negative hormone estrogen and proge

Researchers at Princeton University and Rutgers Cancer Institute of New Jersey in the United States examined Tinagl1’s effects on tumor growth and spread in specially prepared human and mouse tumor-cell models.

According to the research results;

In mouse models, high Tinagl1 activity slowed tumor growth and greatly inhibited metastasis. Tinagl1 inhibited two pathways driving aggressive growth and drug resistance in triple-negative breast cancer.

Tinagl1 suppression of integrin FAK and EGFR signaling in triple-negative breast cancer

Tinagl1 was also injected into mice with breast tumors. After 7 weeks, tumor growth and metastasis were successfully inhibited, with no adverse effects. Tinagl1 also worked when begun immediately after metastasis started.

  • Tinagl1, epidermal growth factor receptor (EGFR) gene activity is halted by it, preventing growth. Epidermal growth factor (EGF) promotes tumor growth. EGFR-targeted therapies have limited effectiveness, so Tinagl1 may offer a new, effective approach.
  • Tinagl1 also affects integrins, important in cell migration to other tissues and organs. Tinagl1 suppresses this pathway by disrupting Focal Adhesion Kinase (FAK) activity.

Both pathways are molecularly linked and promote aggressive triple-negative breast cancer. Tinagl1 may therefore be an effective drug targeting two pathways.

Analyses of over 800 human tumor samples also found that low Tinagl1 gene activity was associated with advanced cancer and shorter survival. High Tinagl1 levels were linked to better outcomes, including in triple-negative patients.

What Does This Study Mean for Us?

Sources

Minhong Shen ve ark.
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
Cancer Cell, 3 January 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Natural Protein Tinagl1 May Prevent Breast Cancer Cell Growth and Metastasis

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy